IXICO plc (LON:IXI – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 8.12 ($0.11) and traded as low as GBX 8 ($0.10). IXICO shares last traded at GBX 8.63 ($0.11), with a volume of 520,125 shares trading hands.
IXICO Stock Performance
The firm’s fifty day moving average is GBX 9.20 and its 200 day moving average is GBX 8.12. The company has a market cap of £4.17 million, a PE ratio of -215.63, a price-to-earnings-growth ratio of -0.38 and a beta of 0.86. The company has a current ratio of 3.64, a quick ratio of 4.90 and a debt-to-equity ratio of 3.22.
Insiders Place Their Bets
In other news, insider Mark Warne acquired 26,370 shares of the firm’s stock in a transaction dated Thursday, October 10th. The stock was acquired at an average cost of GBX 9 ($0.12) per share, with a total value of £2,373.30 ($3,089.43). 30.28% of the stock is currently owned by company insiders.
About IXICO
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer.
Read More
- Five stocks we like better than IXICO
- Trading Halts Explained
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- Russell 2000 Index, How Investors Use it For Profitable Trading
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.